Table 2.
Common features at presentation in dialyzed patients with COVID-19
| Features | All patients (n = 44) |
WHO score (2–4) |
WHO score = 5 |
WHO score ≥ 6 |
P |
|---|---|---|---|---|---|
| No oxygen (n = 11, 25%) |
O2 ≤ 6 l/min (n = 14, 31.8%) |
O2 ≥ 9 l/min (n = 19, 43.2%) |
|||
| Clinical symptoms | |||||
| Fever / chills | 35 (79.5) | 8 (72.7) | 10 (71.4) | 17 (89.5) | Ns |
| Oxygen requirement | 20 (45.5) | 0 (0.0) | 6 (42.9) | 14 (73.7) | |
| Cough | 19 (43.2) | 4 (36.4) | 5 (35.7) | 10 (52.63) | Ns |
| Shortness of breath | 13 (29.5) | 0 (0.0) | 4 (28.6) | 9 (47.4) | Ns |
| Diarrhea | 6 (13.6) | 0 (0.0) | 3 (21.4) | 3 (15.8) | Ns |
| Anorexia and weigh loss | 26 (59.1) | 8 (72.7) | 10 (71.4) | 8 (42.1) | Ns |
| SARS-CoV-2 RT-PCR | |||||
| Positive | 43 (97.7) | 10 (90.9) | 14 (100) | 19 (100) | Ns |
| Delay from initial signs, d | 1 (0–2) | 0 (0–1) | 1 (0–3) | 1 (1–5) | 0.04 |
| Chest CT-scan | |||||
| Delay from initial signs, d | 2 (0–5) | 0 (0–6) | 2 (0–3) | 2.5 (1–6) | Ns |
| Normal | 8 (19.5) | 3 (33.3) | 2 (14.3) | 3 (16.7) | Ns |
| Mild | 9 (22.0) | 2 (22.2) | 5 (35.7) | 2 (11.1) | Ns |
| Moderate | 11 (26.8) | 2 (22.2) | 5 (35.7) | 4 (22.2) | Ns |
| Severe | 13 (31.7) | 2 (22.2) | 2 (14.3) | 9 (50.0) | 0.08 |
| Biochemical parameters | |||||
| Sodium level, mmol/l | 138 (136.5–140) | 137 (135–140) | 139 (137–141) | 138 (135–139) | Ns |
| Bicarbonate level, mmol/l | 24 (21–26) | 25 (21–25) | 24.5 (23–26) | 24 (20–26) | Ns |
| Albumin level, g/l | 32.5 (24–38) | 35 (28–39) | 33 (23–40) | 32 (21–35) | Ns |
| LDH level, n < 250 UI/l | 313 (206–377) | 198 (141–320) | 313 (254–438) | 315.5 (239–328) | Ns |
| CRP level, mg/l | 65 (6–123) | 5 (5–44) | 71.5 (18–120) | 91.5 (16–138) | 0.01 |
| Fibrinogen level, g/l | 5.4 (4.25–6.1) | 4.35 (3.4–5.4) | 5.6 (4.4–6.5) | 5.4 (4.3–6.2) | Ns |
| D-dimers level, UI/l | 715 (515–970) | 715 (515–970) | 1690 (540–2830) | 1640 (880–3575) | Ns |
| Hematological parameters | |||||
| Hemoglobin level, g/dl | 10.4 (9.45–11.8) | 11.8 (9.3–12.5) | 9.95 (9.5–11.0) | 10.4 (8.9–11.7) | Ns |
| Platelet count, g/l | 196.5 (136–249) | 250 (164–364) | 165 (123–237) | 195 (133–218) | 0.07 |
| Lymphocyte count, g/l | 0.6 (0.46–1.04) | 0.68 (0.53–1.2) | 0.60 (0.48–1.28) | 0.57 (0.41–0.97) | Ns |
| Neutrophil count, g/l | 3.91 (2.39–6.00) | 2.85 (2.14–4.92) | 4.23 (2.42–6.2) | 4.38 (3.26–7.56) | Ns |
CRP, C-reactive protein; COVID-19, coronavirus disease 2019; CT, computed tomography; LDH, lactate dehydrogenase; ns, a nonsignificant P value; RT-PCR, reverse transcriptase–polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Data are n (%) or median (interquartile range).